Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Keywords » - entrée « Adult »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Adrenocorticotropic Hormone (blood) < Adult < Adult onset Still’s disease  Facettes :

List of bibliographic references indexed by Adult

Number of relevant bibliographic references: 687.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000009 (2020) C B Wu [République populaire de Chine] ; H Y Zhang [République populaire de Chine] ; S H Shao [République populaire de Chine] ; L W Dou [République populaire de Chine] ; Q Y Zhou [République populaire de Chine] ; Y. Liu [République populaire de Chine] ; W B Gao [République populaire de Chine] ; J H Zhu [République populaire de Chine][A report of six TAFRO syndrome: clinical characteristics, diagnosis and treatment analysis].
000149 (2020) Emre Bilgin [Oman] ; Rem Ozarli [Turquie] ; Levent K L Ç [Turquie] ; Ertu Rul Ça R Bölek [Turquie] ; Gözde Kübra Yard Mc [Turquie] ; Ömer Karada [Turquie]Some concerns from Turkey.
000190 (2020) Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Kei Ikeda [Japon] ; Tomonori Ishii [Japon] ; Kosaku Murakami [Japon] ; Hyota Takamatsu [Japon] ; Yoshiya Tanaka [Japon] ; Takayuki Abe [Japon] ; Tsutomu Takeuchi [Japon]Response to: 'Some concerns from Turkey' by Bilgin et al.
000350 (2020) Anna-Sophia Kattner ; Ernst Holler ; Barbara Holler ; Sebastian Klobuch ; Daniela Weber ; Danilo Martinovic ; Matthias Edinger ; Wolfgang Herr ; Daniel WolffIL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
000351 (2020) Etienne Dufranc [France] ; Arnaud Del Bello [France] ; Julie Belliere [France] ; Nassim Kamar [France] ; Stanislas Faguer [France]IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome
000571 (2020) Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon ChoeAssociation between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.
000700 (2019) Martin Krusche [Allemagne] ; Nikolas Ruffer [Allemagne] ; Ina Kötter [Allemagne]Tocilizumab treatment in refractory polyarteritis nodosa: a case report and review of the literature.
000708 (2019) Young Ho Lee [Corée du Sud]Tocilizumab in patients with adult-onset Still's disease refractory to glucocorticoid treatment.
000713 (2019) Alex Ganetsky [États-Unis] ; Noelle V. Frey [États-Unis] ; Elizabeth O. Hexner [États-Unis] ; Alison W. Loren [États-Unis] ; Saar I. Gill [États-Unis] ; Selina M. Luger [États-Unis] ; James K. Mangan [États-Unis] ; Mary Ellen Martin [États-Unis] ; Daria V. Babushok [États-Unis] ; William R. Drobyski [États-Unis] ; Jacqueline Smith [États-Unis] ; Colleen Timlin [États-Unis] ; Craig W. Freyer [États-Unis] ; Edward A. Stadtmauer [États-Unis] ; David L. Porter [États-Unis]Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
000715 (2019) Santos Casta Eda [Espagne] ; Dolores Martínez-Quintanilla [Espagne] ; José L. Martín-Varillas [Espagne] ; Noelia García-Casta Eda [Espagne] ; Belén Atienza-Mateo [Espagne] ; Miguel A. González-Gay [Espagne]Tocilizumab for the treatment of adult-onset Still's disease.
000716 (2019) Chipman Rg Stroud [États-Unis] ; Aparna Hegde [États-Unis] ; Cynthia Cherry [États-Unis] ; Abdul R. Naqash [États-Unis] ; Nitika Sharma [États-Unis] ; Srikala Addepalli [États-Unis] ; Sulochana Cherukuri [États-Unis] ; Teresa Parent [États-Unis] ; Jessica Hardin [États-Unis] ; Paul Walker [États-Unis]Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
000719 (2019) Kazutoshi Ebisawa [Japon] ; Yosuke Masamoto [Japon] ; Junji Tokushige [Japon] ; Hiroshi Nishi [Japon] ; Kenjiro Honda [Japon] ; Munetoshi Hinata [Japon] ; Kazuhiro Toyama [Japon] ; Masaomi Nangaku [Japon] ; Mineo Kurokawa [Japon]Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease.
000721 (2019) Jumpei Saito ; Naho Yakuwa ; Kayoko Kaneko [Japon] ; Chinatsu Takai ; Mikako Goto ; Ken Nakajima ; Akimasa Yamatani ; Atsuko MurashimaTocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum.
000728 (2019) Liyang Gu [Oman] ; Shuang YeTocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic Pemphigus.
000732 (2019) Matthew J. Frigault ; Jorg Dietrich ; Maria Martinez-Lage ; Mark Leick ; Bryan D. Choi ; Zachariah Defilipp ; Yi-Bin Chen ; Jeremy Abramson ; Jennifer Crombie [États-Unis] ; Philippe Armand [États-Unis] ; Lakshmi Nayak [États-Unis] ; Chris Panzini ; Lauren S. Riley ; Kathleen Gallagher ; Marcela V. MausTisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.
000763 (2019) Li Zhou [République populaire de Chine] ; Dong-Mei Xiao [République populaire de Chine] ; Wen Qin [République populaire de Chine] ; Bin-Hua Xie [République populaire de Chine] ; Ting-Hui Wang [République populaire de Chine] ; Hua Huang [République populaire de Chine] ; Bao-Jing Zhao [République populaire de Chine] ; Xi Han [République populaire de Chine] ; Qing-Qing Sun [République populaire de Chine] ; Xiu-Di Wu [République populaire de Chine] ; Han Cen [République populaire de Chine]The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab.
000831 (2019) Laura Bazzichi [Italie] ; Francesca Nacci [Italie] ; Luigi Sinigaglia [Italie] ; Laura Bianchino [Italie] ; Roberto Caporali [Italie]Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial.
000852 (2019) Bartosz Urbaniak [Pologne] ; Szymon Plewa [Pologne] ; Agnieszka Klupczynska [Pologne] ; Dorota Sikorska [Pologne] ; Włodzimierz Samborski [Pologne] ; Zenon J. Kokot [Pologne]Serum free amino acid levels in rheumatoid arthritis according to therapy and physical disability.
000855 (2019) Christoph T. Berger [Suisse] ; Birke Rebholz-Chaves [Suisse] ; Mike Recher [Suisse] ; Tobias Manigold [Suisse] ; Thomas Daikeler [Suisse]Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.
000867 (2019) Paul Emery [Royaume-Uni] ; Juan Rondon [États-Unis] ; Janie Parrino [États-Unis] ; Yong Lin [États-Unis] ; Claudia Pena-Rossi [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Neil M H. Graham [États-Unis] ; Nancy Liu [États-Unis] ; Anne Paccaly [États-Unis] ; Richard Wu [États-Unis] ; Alberto Spindler [Argentine]Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis.
000870 (2019) Ching-Tsai Lin [Taïwan] ; Wen-Nan Huang [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Yi-Ming Chen [Taïwan] ; Der-Yuan Chen [Taïwan] ; Tsu-Yi Hsieh [Taïwan] ; Yi-Hsing Chen [Taïwan]Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis - A three-year study in Taiwan.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Adult" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Adult" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Adult
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021